Glaucoma is the second leading cause of blindness in the world, especially among the elderly. As our population grows and people live longer, more of us will experience sight loss caused by glaucoma and face the challenges that losing vision in later life can bring.

This research will identify a list of potential genes, proteins and chemical components which can be immediately tested for clinical usefulness. It is through the identification of new genetic variations which cause glaucoma, that new treatments will be developed.